Olema Pharmaceuticals, Inc. (OLMA)
13.19
+0.43
(+3.37%)
USD |
NASDAQ |
May 29, 16:00
13.57
+0.38
(+2.88%)
After-Hours: 07:22
Olema Pharmaceuticals Total Liabilities (Quarterly) : 50.17M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 39.41M |
| Praxis Precision Medicines, Inc. | 50.24M |
| Nuvalent, Inc. | 156.78M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 530.64M |
| Shareholders Equity (Quarterly) | 480.48M |
| Debt to Equity Ratio | 0.0082 |
| Current Ratio | 10.88 |
| Net Debt Paydown Yield | -0.04% |